ABEO Insider Trading Activity and SEC Form 4 Filings
ABEO insider trading summary
Over the past 12 months, insiders at Abeona Therapeutics Inc. (ABEO) reported 36 sales worth $3.4M by 9 insiders and no open-market purchases on SEC Form 4. Net insider selling was $3.4M.
Latest ABEO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 29, 2026 | Joseph Walter Vazzano | Chief Financial Officer | Sell | $47K (9,191 @ $5.16) |
| Sep 29, 2026 | Madhav Vasanthavada | Chief Commercial Officer | Sell | $25K (4,902 @ $5.16) |
| Sep 29, 2026 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | $35K (6,727 @ $5.16) |
| Sep 29, 2026 | Vishwas Seshadri | Chief Executive Officer | Sell | $101K (19,608 @ $5.16) |
| Sep 1, 2026 | Mark Alvino | Director | Sell | $88K (15,000 @ $5.86) |
| Jul 21, 2026 | Joseph Walter Vazzano | Chief Financial Officer | Sell | $10K (1,478 @ $6.53) |
| Jul 9, 2026 | Brendan M. O'Malley | SVP, Chief Legal Officer | Sell | $84K (12,050 @ $6.96) |
| Jul 9, 2026 | Vishwas Seshadri | Chief Executive Officer | Sell | $473K (67,971 @ $6.96) |
| Jul 9, 2026 | Madhav Vasanthavada | Chief Commercial Officer | Sell | $88K (12,606 @ $6.96) |
| Jul 9, 2026 | Joseph Walter Vazzano | Chief Financial Officer | Sell | $173K (24,880 @ $6.96) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.